Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co (4507.T) and AnGes Inc (4563.T).
Japan has not suffered the explosive surge of coronavirus infections seen in some other countries. It has reported around 17,000 confirmed cases and 900 known deaths to date.
https://www.reuters.com/article/us-health-coronavirus-japan-vaccine/japan-aims-to-have-coronavirus-vaccines-in-use-by-june-2021-idUSKBN23C1S0
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.